Drug Approval | April 07, 2022
Lupin launches Merzee capsules in the United States
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
Subscribe To Our Newsletter & Stay Updated
